Skip Navigation


Europace Advance Access originally published online on May 23, 2007
Europace 2007 9(9):817-822; doi:10.1093/europace/eum093
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
9/9/817    most recent
eum093v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Williams, L.
Right arrow Articles by Frenneaux, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, L.
Right arrow Articles by Frenneaux, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

SYNCOPE

Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment

Lynne Williams* and Michael Frenneaux

1 Department of Cardiovascular Medicine, University of Birmingham, Edgbaston, Birmingham B15 2TT, West Midlands, UK

Hypertrophic cardiomyopathy (HCM) is an inherited disease with marked phenotypic variability that includes the extent of hypertrophy, the presence and severity of symptoms, and the natural history of the disease. Symptoms of impaired consciousness (syncope and pre-syncope) occur in approximately 15–25% of patients with hypertrophic cardiomyopathy (HCM). In young patients a history of recurrent syncope is associated with an increased risk of sudden death. Detailed investigations identify a probable mechanism in a minority of these, usually paroxysmal atrial fibrillation or ventricular tachycardia. In the majority, however, no likely mechanism is found despite extensive investigation. Although this may be the case, it is still of vital importance to exclude potentially treatable causes of syncope.

Key Words: Hypertrophic cardiomyopathy, Syncope, Sudden death, Arrhythmias, Abnormal vascular control

* Corresponding author. Tel: +44 121 415 8825; fax: +44 121 414 3713. E-mail address: l.k.williams{at}bham.ac.uk

Manuscript submitted 28 February 2007. Accepted after revision 7 April 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
P. Elliott and W. McKenna
The Science of Uncertainty and the Art of Probability: Syncope and Its Consequences in Hypertrophic Cardiomyopathy
Circulation, April 7, 2009; 119(13): 1697 - 1699.
[Full Text] [PDF]

Home page
 BMJ Case ReportsHome page
I. Iniesta, R. Yotti, and A. Garcia-Pastor
Transient loss of consciousness with convulsions in two young adults with potentially fatal underlying heart disease: syncope versus seizures
BMJ Case Reports, March 20, 2009; 2009(mar19_1): bcr0620080285 - bcr0620080285.
[Abstract] [Full Text]

Home page
 Eur Heart JHome page
S. Sen-Chowdhry and W. J. McKenna
Non-invasive risk stratification in hypertrophic cardiomyopathy: don't throw out the baby with the bathwater
Eur. Heart J., July 1, 2008; 29(13): 1600 - 1602.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.